Interferon alfa and famciclovir for chronic HBsAg and anti-HBe positive patients - An interim analysis.

被引：0
|
作者：
Sentjens, RE [1 ]
Beld, M [1 ]
Rebers, S [1 ]
Reesink, HW [1 ]
机构：
[1] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands
来源：
HEPATOLOGY | 2001年 / 34卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1838
引用
收藏
页码：631A / 631A
页数：1
相关论文
共 50 条
  • [41] Reduction of liver cell proliferation in patients with anti-HBE chronic hepatitis B treated with interferon (IFN).
    Donato, MF
    Lampertico, P
    Arosio, E
    Del Ninno, E
    Ronchi, G
    Morabito, A
    Fasani, P
    Colombo, M
    HEPATOLOGY, 1999, 30 (04) : 345A - 345A
  • [42] Famciclovir treatment of anti-HBe plus chronic hepatitis B:: Results of a randomized, placebo-controlled study
    Tassopoulos, N
    Hadziyannis, S
    Idéo, G
    Jurewicz, R
    Young, C
    Saltzman, R
    Trepo, C
    Bonino, F
    JOURNAL OF HEPATOLOGY, 2000, 32 : 102 - 102
  • [43] Igm anti-HBc as diagnostic criterium for chronic anti-HBe positive hepatitis B
    Colombatto, P
    Oliveri, F
    Randone, A
    Gallo, M
    Verme, G
    Flichman, D
    Bonino, F
    Brunetto, MR
    HEPATOLOGY, 1996, 23 (01) : P109 - P109
  • [44] Lamivudine monotherapy and interferon plus lamivudine combination therapy in anti-HBe positive patients with chronic hepatitis B who have failed previously interferon treatment
    Akarca, US
    Ersoz, G
    Karasu, Z
    Gunsar, F
    Kilincsoy, N
    Batur, Y
    JOURNAL OF HEPATOLOGY, 2001, 34 : 167 - 167
  • [45] Chronic HBV infection. Immunomodulation with levamisole in viremic HBeAg positive or Anti-HBe positive patients - A pilot study
    Krastev, Z
    Jelev, D
    Antonov, K
    Alagozian, V
    Kotzev, I
    HEPATO-GASTROENTEROLOGY, 1999, 46 (30) : 3184 - 3188
  • [46] Long term monthly follow-up of patients chronic anti-HBe positive hepatitis B treated different interferon types and schedules
    Oliveri, F
    Santantonio, T
    Bellati, G
    Colloredo, G
    Colombatto, P
    Dastoli, G
    Bonino, F
    Brunetto, MR
    HEPATOLOGY, 1996, 23 (01) : P201 - P201
  • [47] Cytotoxic T lymphocyte responses and CTL epitope escape mutation in HBsAg, anti-HBe positive individuals
    Khakoo, SI
    Ling, R
    Scott, I
    Dodi, AI
    Harrison, TJ
    Dusheiko, GM
    Madrigal, JA
    GUT, 2000, 47 (01) : 137 - 143
  • [48] RELATIONSHIP OF HBSAG SUBTYPES WITH HBEAG ANTI-HBE STATUS AND CHRONIC LIVER-DISEASE .1. ANALYSIS OF 1744 HBSAG-CARRIERS
    SHIINA, S
    FUJINO, H
    UTA, Y
    TAGAWA, K
    UNUMA, T
    YONEYAMA, M
    OHMORI, T
    SUZUKI, S
    KURITA, M
    OHASHI, Y
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1991, 86 (07): : 866 - 870
  • [49] VIRAL REPLICATION AND CLINICAL EVOLUTION OF ANTI-HBE POSITIVE CHRONIC B-HEPATITIS
    SANCHEZTAPIAS, J
    MAS, A
    COSTA, J
    BALLESTA, A
    BRUGUERA, M
    RODES, J
    JOURNAL OF HEPATOLOGY, 1988, 6 (03) : P25 - P26
  • [50] HBEAG/ANTI-HBE SYSTEM AND DEVELOPMENT OF PRIMARY HEPATOCELLULAR-CARCINOMA IN PATIENTS WITH HBSAG-POSITIVE LIVER-CIRRHOSIS
    MUSCA, A
    CORDOVA, C
    BARNABA, V
    BONAVITA, MS
    LEVRERO, M
    ZACCARI, C
    BALSANO, F
    HEPATO-GASTROENTEROLOGY, 1983, 30 (01) : 3 - 5
12345